Glenmark Pharma shares soar 8% on FDA clean report, Investec predicts 17% upside

September 23, 2024

The global brokerage firm said that it expects both earnings momentum and importantly cash flow generation to continue. Additionally, it sees Glenmark as more of an India / RoW play as these two contribute >70% of its EBITDA.

More To Explore

No AGR relief, a higher proportion of telecom debt may get converted into equity: Balaji Subramanian

The Supreme Court has rejected the plea by telecom companies for re-computation of adjusted gross revenue (AGR), leaving no relief for major players like Vodafone

September 23, 2024

Casagrand Premier Builder files DRHP for Rs 1,100 crore IPO

Casagrand Premier Builder has filed a draft red herring prospectus with SEBI to raise Rs 1,100 crore through an IPO. The funds will be used

September 23, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003